Dr. Reinhold Maeck, Boehringer Ingelheim - Qepler Summits And Conferences

Dr. Reinhold Maeck

Head of Corp EHS Regulatory Intelligence
Boehringer Ingelheim
Cleveland, Ohio, USA
At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we p

2012 – July 2014: Associate Director, Tech.-Transfer at Boehringer Ingelheim; Ben Venue Laboratories, USA

June 2009 – 2011: Director Center of Competence and Projects at Boehringer Ingelheim China

2008 – 2009: Senior Project Manager Operations at Boehringer Ingelheim Corporate, Germany

September 2000 – December 2007: Head of Production Pharma Chemicals at Boehringer Ingelheim

1991 and 2007: Different management positions in Chemical Production, Corporate HSE (introduction of internal auditing) and Quality Control at Boehringer Ingelheim and Ciba Geigy.


1988 – 1991: Ph.D. European Commission, Joint Research Centre in Antwerp, Belgium

- 1988: International studies of Chemistry and Chemical Engineering in France (Grande Ecole) and Germany (University of Saarbrück)

Related Sessions:

2nd Annual Highly Potent APIs
Summit 2020

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 19 Feb 2020
  • Prague, CZ
  • Pharma
Day 1: Wednesday, 19 February 2020
CASE STUDY: PDE evaluation and OEL setting in an HPAPI environment, what to consider in factories from a legal background
View Details